Asian Growth Stocks With Significant Insider Ownership

As global markets react positively to the recent de-escalation in U.S.-China trade tensions, Asian stocks are seeing renewed interest from investors looking for growth opportunities. In this environment, companies with high insider ownership often stand out as they may indicate confidence from those who know the business best.

Advertisement

Top 10 Growth Companies With High Insider Ownership In Asia

NameInsider OwnershipEarnings Growth
Sineng ElectricLtd (SZSE:300827)36%26.9%
Schooinc (TSE:264A)26.6%68.9%
Nanya New Material TechnologyLtd (SHSE:688519)11%63.3%
Global Tax Free (KOSDAQ:A204620)20.8%35.1%
Oscotec (KOSDAQ:A039200)21.1%94.4%
Fulin Precision (SZSE:300432)13.6%44.2%
M31 Technology (TPEX:6643)30.8%63.4%
Zhejiang Leapmotor Technology (SEHK:9863)15.6%60%
Vuno (KOSDAQ:A338220)15.6%109.8%
Techwing (KOSDAQ:A089030)18.8%68%

Click here to see the full list of 621 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

CanSino Biologics (SEHK:6185)

Simply Wall St Growth Rating: ★★★★★☆

Overview: CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People’s Republic of China, with a market cap of HK$12.06 billion.

Operations: The company generates revenue from its vaccine product research and development for human use, amounting to CN¥869.22 million.

Insider Ownership: 31.4%

CanSino Biologics is poised for significant growth, with earnings forecasted to increase by 158.69% annually and revenue expected to grow at 30.7% per year, surpassing the Hong Kong market average. Despite trading well below its estimated fair value, the company's return on equity is projected to remain low at 9.1%. Recent developments include a Phase I trial approval in Indonesia for an innovative inhaled tuberculosis vaccine and a strategic collaboration in Saudi Arabia for vaccine commercialization, enhancing its global footprint.

SEHK:6185 Earnings and Revenue Growth as at May 2025
SEHK:6185 Earnings and Revenue Growth as at May 2025

OSL Group (SEHK:863)

Simply Wall St Growth Rating: ★★★★★☆

Overview: OSL Group Limited is an investment holding company that operates in the digital assets and blockchain platform sector across Hong Kong, Australia, Japan, Singapore, and Mainland China with a market cap of HK$7.90 billion.

Operations: The company generates revenue of HK$374.75 million from its digital assets and blockchain platform business across several key markets, including Hong Kong, Australia, Japan, Singapore, and Mainland China.

Insider Ownership: 33.8%

OSL Group is set for robust growth, with revenue projected to rise by 32.5% annually, outpacing the Hong Kong market. Earnings are expected to increase significantly at 60% per year. The company recently launched OSL Wealth, a platform for managing crypto assets, leveraging Hong Kong's financial hub status. Despite becoming profitable this year with sales reaching HK$374.75 million and net income of HK$47.65 million, its future return on equity remains modest at 19.6%.

SEHK:863 Earnings and Revenue Growth as at May 2025
SEHK:863 Earnings and Revenue Growth as at May 2025

Suzhou Dongshan Precision Manufacturing (SZSE:002384)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Suzhou Dongshan Precision Manufacturing Co., Ltd. operates in the precision manufacturing industry with a market cap of CN¥50.03 billion.

Operations: The company generates revenue from various segments in the precision manufacturing industry, with total revenues detailed in millions of CN¥.

Insider Ownership: 28.6%

Suzhou Dongshan Precision Manufacturing's recent buyback of 4.2 million shares for CNY 100.08 million highlights its commitment to shareholder value, though insider ownership details over the past three months are unavailable. Despite a volatile share price and profit margins declining from 5.1% to 3.3%, earnings are forecasted to grow significantly at 36.5% annually, surpassing market expectations, while revenue growth is projected at a slower pace of 14.2%.

SZSE:002384 Earnings and Revenue Growth as at May 2025
SZSE:002384 Earnings and Revenue Growth as at May 2025

Key Takeaways

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About SEHK:6185

CanSino Biologics

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

Very undervalued with high growth potential.

Advertisement

Weekly Picks

ST
stuart_roberts
UG logo
stuart_roberts on Upside Gold ·

An Undervalued 3.3Moz Gold Project in Canada

Fair Value:CA$5.0768.0% undervalued
287 users have followed this narrative
1 users have commented on this narrative
42 users have liked this narrative
GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8591.3% undervalued
100 users have followed this narrative
2 users have commented on this narrative
28 users have liked this narrative
TO
Tokyo
ABI logo
Tokyo on Anheuser-Busch InBev ·

EU#8 - Anheuser-Busch InBev: Courage, Capital, and the Discipline to Build an Empire

Fair Value:€89.4524.2% undervalued
8 users have followed this narrative
3 users have commented on this narrative
4 users have liked this narrative
OS
oscargarcia
AMZN logo
oscargarcia on Amazon.com ·

The capitalist colossus that makes your parcels magically appear, powers half the internet, and knows your shopping habits.

Fair Value:US$2803.2% undervalued
62 users have followed this narrative
1 users have commented on this narrative
2 users have liked this narrative

Updated Narratives

DE
Degen_GCR
P logo
Degen_GCR on Everpure ·

Second order memory play likely to double in a year

Fair Value:US$18057.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
HE
HedgeY
NWRN logo
HedgeY on Newron Pharmaceuticals ·

Still A Binary Phase III Bet on Evenamide

Fair Value:CHF 1824.4% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
HE
HedgeY
KIN logo
HedgeY on Kinepolis Group ·

A Premium Cinema Operator With a Quietly Compounding Cash Machine

Fair Value:€3515.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8591.3% undervalued
100 users have followed this narrative
2 users have commented on this narrative
28 users have liked this narrative
KI
NVDA logo
Kingman1152 on NVIDIA ·

NVIDIA will see a profit margin surge of 55% in the next 5 years

Fair Value:US$305.229.5% undervalued
69 users have followed this narrative
2 users have commented on this narrative
24 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$561.9326.1% undervalued
1399 users have followed this narrative
2 users have commented on this narrative
12 users have liked this narrative